COMP <GO>
GUTS vs FEMY // EV/EBITDA & P/E VALUATION
Fractyl Health Inc. (NASDAQ) VS. Femasys Inc. (NASDAQ) • 15-METRIC TALLY: GUTS 2
— FEMY 1
■ METRIC PARITY
LAST: $0.99 (+11.40%) • MKT CAP: $13.2M
valuation
—
LAST: $1.36 (-3.90%) • MKT CAP: $11.3M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GUTS VS. FEMY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GUTS | FEMY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 62.00% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 40.80% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 4/9 | -2.00 | FEMY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 84.0 | 27.5 | +56.48 | GUTS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $13.2M | $11.3M | $1.8M | GUTS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GUTS REV | FEMY REV | GUTS GROSS % | FEMY GROSS % | GUTS FCF | FEMY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $2.3M | — | 62.0% | -$90.9M | -$19.2M |
| FY 2024 | $93.0K | $1.6M | 46.2% | 66.6% | -$67.3M | -$20.2M |
| FY 2023 | $0 | $1.1M | — | — | -$42.8M | -$11.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GUTS // BETA —
FEMY // BETA —